Sandoz Group AG - Asset Resilience Ratio

Latest as of June 2025: 6.43%

Sandoz Group AG (SDZ) has an Asset Resilience Ratio of 6.43% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CHF1.39 Billion
Cash + Short-term Investments

Total Assets

CHF21.61 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2023–2024)

This chart shows how Sandoz Group AG's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Sandoz Group AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CHF1.39 Billion 6.43%
Short-term Investments CHF0.00 0%
Total Liquid Assets CHF1.39 Billion 6.43%

Asset Resilience Insights

  • Limited Liquidity: Sandoz Group AG maintains only 6.43% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Sandoz Group AG Industry Peers by Asset Resilience Ratio

Compare Sandoz Group AG's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.72%
Chongkundang
KO:001630
Drug Manufacturers - Specialty & Generic 3.13%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000225
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Sandoz Group AG (2023–2024)

The table below shows the annual Asset Resilience Ratio data for Sandoz Group AG.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 5.98% CHF1.19 Billion CHF19.91 Billion +1.18pp
2023-12-31 4.80% CHF933.39 Million CHF19.43 Billion --
pp = percentage points

About Sandoz Group AG

SW:SDZ Switzerland Drug Manufacturers - Specialty & Generic
Market Cap
$35.57 Billion
CHF28.13 Billion CHF
Market Cap Rank
#789 Global
#8 in Switzerland
Share Price
CHF65.32
Change (1 day)
-3.83%
52-Week Range
CHF32.36 - CHF72.42
All Time High
CHF72.42
About

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage f… Read more